Recent studies have increasingly implicated miRNAs in AD pathology; miRNAs regulate the expression of APP [42–45] and proteins involved in APP metabolism, such as α-secretase, ADAM10 [46, 47], β-secretase, and BACE1 [48, 49]. Here, BACE1 is linked to Alzheimer disease.